Recent Blog Posts

View Post: psoriasis:OSI-906 In Clinical Trial For Adrenocort
20 Nov 2009 by psoriasis0  
TGen Clinical Research Services at Scottsdale Healthcare have announced the start of a clinical trial for a drug designed to combat adrenocortical carcinoma (ACC), a rare but deadly cancer that attacks the adrenal glands. ...
View Blog: Psoriasis - http://psoriasis0.amznstore.com/

---

View Post: New Drug May Offer Hope for Adrenocortical Carcinoma Patients
3 Oct 2009 by Standplaats: Amerika  
TGen Clinical Research Services (TCRS) at Scottsdale Healthcare in Scottsdale, Arizona, recently announced the start of a clinical trial for a drug designed to combat adrenocortical carcinoma (ACC), a rare but deadly cancer that forms ...
View Blog: Onco'Zine - The International Cancer Blog - http://oncozine.blogspot.com/

---

View Post: An Article on Cancer
Cancer
Medical Health Center ...
View Blog: Bladder Cancer. Bone Cancer. Bile Duct Cancer. Brain Tumour. Appendix Cancer. Adrenocortical Carcinoma. Cervical cancer. Childhood cancer. Eye Cancer. Gall bladder Cancer. Kidney Cancer. Lip and oral Cancer. Liver Cancer. Mouth Cancer

---

View Post: Bone Morphogenetic Proteins 2 and 5 Are Down-regulated in ...
15 Jul 2009 by Johnsen, IK, Kappler, R., Auernhammer,...  
Quantitative PCR analysis revealed down-regulation of BMP2 and BMP5 in tissue samples from adrenocortical carcinoma and adrenocortical tumor cell lines compared with normal adrenal glands. ... show that loss of expression of members of the BMP family of ligands is a common finding in adrenocortical tumors and we provide evidence that BMP-dependent pathways are likely to be involved in the modulation of the malignant and functional phenotype of adrenocortical cancer cells. ...
View Blog: Cancer Research current issue - http://cancerres.aacrjournals.org/

---

View Post: Adrenocortical carcinoma survival rates correlated to genomic copy ...
15 Feb 2008 by Stephan, EA, Chung, T.-H., Grant, CS, Kim,...  
Adrenocortical carcinoma (ACC) is a rare endocrine malignancy accounting for between 0.02% and 0.2% of all cancer deaths. Surgical removal offers the only current potential for cure. Unfortunately, ACC has undergone metastatic spread in ...
View Blog: Molecular Cancer Therapeutics current issue - http://mct.aacrjournals.org/

---

View Post: Katie Gerstenberger Endowment: Endowment Income - What's in Store ...
20 Oct 2009 by karen gerstenberger  
The thinking about adrenocortical carcinoma is that it is a slow-growing cancer; this was clearly not the case for Katie! Obviously, more needs to be known about pediatric cancer, which is the main reason why Katie wanted her Endowment ...
View Blog: Katie Gerstenberger Endowment - http://katiegerstenbergerendowment.blogspot.com/

---

View Post: JCO review: Management of endocrine manifestations of ...
11 Aug 2009
The Journal of Clinical Oncology has featured a review on the management of endocrine manifestations of adrenocortical carcinoma, and the use of mitotane as a chemotherapeutic agent for this cancer. The review also discusses treatment ...
View Blog: NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/

---

View Post: What's causing my frequent urination?
Prostate Cancer Therapy
27 Oct 2009 by admin   ...
View Blog: http://prostatecancertherapy.org/

---

View Post: PRN: Revolutionary Drug Could Be New Hope for Adrenal Cancer Patients
22 Sep 2009 by jon  
Services at Scottsdale Healthcare today announced the start of a clinical trial for a drug designed to combat adrenocortical carcinoma (ACC), a rare but deadly cancer that attacks the adrenal glands. TCRS is a strategic alliance between ...
View Blog: ScottsdaleNewsReleases - http://scottsdalenewsreleases.blogspot.com/

---